Zejula

Zejula (Niraparib) is a cancer drug that is used to treat ovarian cancer, fallopian tube cancer, or a type of cancer of the abdomen (primary peritoneal cancer). Zejula is given after you have received chemotherapy with cisplatin, oxaliplatin, carboplatin, or similar drugs. Zejula is sold as a brand-name drug only and costs about $27,846.96. However, you can lower your Zejula price to $18,772.91 using a Zejula coupon from SingleCare.

This is a limited availability drug and is not available at most pharmacies

We recommend contacting your insurance company about the availability of this drug.

About Zejula

Zejula (Niraparib) is a cancer drug that is used to treat ovarian cancer, fallopian tube cancer, or a type of cancer of the abdomen (primary peritoneal cancer). Zejula is given after you have received chemotherapy with cisplatin, oxaliplatin, carboplatin, or similar drugs. Zejula is sold as a brand-name drug only and costs about $27,846.96. However, you can lower your Zejula price to $18,772.91 using a Zejula coupon from SingleCare.

About Zejula

Zejula (Niraparib) is a cancer drug that is used to treat ovarian cancer, fallopian tube cancer, or a type of cancer of the abdomen (primary peritoneal cancer). Zejula is given after you have received chemotherapy with cisplatin, oxaliplatin, carboplatin, or similar drugs. Zejula is sold as a brand-name drug only and costs about $27,846.96. However, you can lower your Zejula price to $18,772.91 using a Zejula coupon from SingleCare.

Subscribe to our savings newsletter

Health education, drug info, wellness & more

By clicking 'Subscribe', I agree to SingleCare's Terms & Conditions.